Clinical Trial: Study of the TheraBionic P1 Device in Patients With Metastatic Triple Negative Breast Cancer After Progression

U.S., June 30 -- ClinicalTrials.gov registry received information related to the study (NCT07672431) titled 'Study of the TheraBionic P1 Device in Patients With Metastatic Triple Negative Breast Cancer After Progression' on June 19.

Brief Summary: The goal of this clinical trial is to learn if adding the TheraBionic P1 device to standard of care third line treatment for adult women with metastatic triple negative breast cancer (mTNBC) who have failed, not tolerated, or progressed on standard first- and second-line treatment options can work better than the standard of care alone. The main questions it aims to answer is:

* will the addition of the TheraBionic P1 device to standard of care third line treatment affect progression free and ov...